ID

79

Beschrijving

ODM derived from http://clinicaltrials.gov/ct2/show/record/NCT00661609

Link

http://clinicaltrials.gov/ct2/show/record/NCT00661609

Trefwoorden

  1. 18-11-11 18-11-11 -
  2. 26-03-14 26-03-14 - Martin Dugas
  3. 17-09-21 17-09-21 -
Geüploaded op

18 november 2011

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0 Legacy

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility NCT00661609 Bladder Cancer

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
Beschrijving

Inclusion criteria

Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra)
Beschrijving

Urothelial cancer

Datatype

boolean

Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
Beschrijving

Stage IV

Datatype

boolean

Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting
Beschrijving

Prior chemotherapy

Datatype

boolean

Ambulatory and capable of all selfcare more than 50% of waking hours
Beschrijving

General status

Datatype

boolean

Exclusion criteria
Beschrijving

Exclusion criteria

Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication, 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
Beschrijving

Prior treatment

Datatype

boolean

Inadequate bone marrow reserve
Beschrijving

Bone marrow

Datatype

boolean

Inadequate liver function in the presence of liver metastases
Beschrijving

Liver

Datatype

boolean

Impaired renal function
Beschrijving

Kidney

Datatype

boolean

Medical concepts
Beschrijving

Medical concepts

Diagnosis
Beschrijving

Diagnosis

Datatype

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
LOINC Version 232
MTHU008876
Carcinoma of bladder
Beschrijving

Bladder Cancer

Datatype

string

Alias
UMLS CUI
C0699885
SNOMED CT 2010_0731
255108000
MedDRA 13.1
10005014
Diagnostic Neoplasm Staging
Beschrijving

Tumor Staging

Datatype

string

Alias
UMLS CUI
C0027646
SNOMED CT 2010_0731
254292007
LOINC Version 232
LP78422-0
Chemotherapy
Beschrijving

Chemotherapy

Datatype

string

Alias
UMLS CUI
C0392920
SNOMED CT 2010_0731
150415003
Ambulatory
Beschrijving

Ambulatory

Datatype

string

Alias
UMLS CUI
C0439841
Radiotherapy
Beschrijving

Radiotherapy

Datatype

string

Alias
UMLS CUI
C1522449
SNOMED CT 2010_0731
302505005
White Blood Cells
Beschrijving

WBC

Datatype

string

Alias
SNOMED CT 2010_0731
767002
LOINC Version 232
6690-2
Platelet count - finding
Beschrijving

Platelet count

Datatype

string

Alias
UMLS CUI
C1287267
SNOMED CT 2010_0731
365632008
LOINC Version 232
777-3
Hemoglobin
Beschrijving

Hemoglobin

Datatype

string

Alias
UMLS CUI
C0019046
SNOMED CT 2010_0731
38082009
MedDRA 13.1
10019481
LOINC Version 232
LP14449-0
Metastatic Malignant Neoplasm to the Liver
Beschrijving

Liver Metastasis

Datatype

string

Alias
UMLS CUI
C0494165
SNOMED CT 2010_0731
94381002
MedDRA 13.1
10027457
ICD-10-CM Version 2010
C78.7
ICD-9-CM Version 2011
197.7

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion criteria
Urothelial cancer
Item
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra)
boolean
Stage IV
Item
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
boolean
Prior chemotherapy
Item
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting
boolean
General status
Item
Ambulatory and capable of all selfcare more than 50% of waking hours
boolean
Item Group
Exclusion criteria
Prior treatment
Item
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication, 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
boolean
Bone marrow
Item
Inadequate bone marrow reserve
boolean
Liver
Item
Inadequate liver function in the presence of liver metastases
boolean
Kidney
Item
Impaired renal function
boolean
Item Group
Medical concepts
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
MTHU008876 (LOINC Version 232)
Bladder Cancer
Item
Carcinoma of bladder
string
C0699885 (UMLS CUI)
255108000 (SNOMED CT 2010_0731)
10005014 (MedDRA 13.1)
Tumor Staging
Item
Diagnostic Neoplasm Staging
string
C0027646 (UMLS CUI)
254292007 (SNOMED CT 2010_0731)
LP78422-0 (LOINC Version 232)
Chemotherapy
Item
Chemotherapy
string
C0392920 (UMLS CUI)
150415003 (SNOMED CT 2010_0731)
Ambulatory
Item
Ambulatory
string
C0439841 (UMLS CUI)
Radiotherapy
Item
Radiotherapy
string
C1522449 (UMLS CUI)
302505005 (SNOMED CT 2010_0731)
WBC
Item
White Blood Cells
string
767002 (SNOMED CT 2010_0731)
6690-2 (LOINC Version 232)
Platelet count
Item
Platelet count - finding
string
C1287267 (UMLS CUI)
365632008 (SNOMED CT 2010_0731)
777-3 (LOINC Version 232)
Hemoglobin
Item
Hemoglobin
string
C0019046 (UMLS CUI)
38082009 (SNOMED CT 2010_0731)
10019481 (MedDRA 13.1)
LP14449-0 (LOINC Version 232)
Liver Metastasis
Item
Metastatic Malignant Neoplasm to the Liver
string
C0494165 (UMLS CUI)
94381002 (SNOMED CT 2010_0731)
10027457 (MedDRA 13.1)
C78.7 (ICD-10-CM Version 2010)
197.7 (ICD-9-CM Version 2011)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial